FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo
FRANKFURT (Reuters) – A pending U.S. lawsuit over claims related to Bayer’s (BAYGn.DE) glyphosate-based herbicide Roundup has been delayed, the company said on Sunday, with a new court date set for February, 2020.
“The Oct. 15, 2019 trial date for Winston v. Monsanto in St. Louis City has been postponed,” Bayer said in a statement.
The lawsuit is the latest of several to be delayed as mediator Ken Feinberg tries to negotiate a settlement between the company and U.S. plaintiffs after a California jury in August last year found that Monsanto should have warned of alleged cancer risks.
“With the change in the trial schedule and no trial dates set through the rest of the year, the appeals of the three completed trials will be a significant focus of the litigation in the months ahead,” Bayer said.
Handelsblatt first reported the latest delay earlier on Sunday.
A court document from the Circuit Court of the City of St. Louis, dated October 4, said a new court date had been set for February 10.
The number of U.S. plaintiffs blaming Roundup and other glyphosate-based weed killers for cancer has been rising continuously to stand at 18,400 as of July 11, hitting Bayer’s share price.
Reporting by Tina Bellon; Editing by Kirsten Donovan
more recommended stories
Mexico in ‘bad shape’ with coronavirus pandemic, WHO chief warns
The head of the World Health.
Coronavirus surge in Mississippi depletes ICU bed availability in state’s capital: official
A surge in cases and hospitalizations.
Some HIV patients with ‘powerful immune systems’ may naturally clear HIV infections: study
A small percentage of HIV patients may.
Blood thinners may increase coronavirus survival by 50%, decrease intubations 30%: Study
Anticoagulants may increase survival rates in.
Mask-wearing employees at Starbucks in South Korea avoid coronavirus infection following outbreak: officials
An outbreak of the novel coronavirus.
Coronavirus survivors plagued by long-term ailments
The novel coronavirus isn’t done with.
Risks grow for special ed students as remote classes stretch into new school year
As more schools prepare to start.
Millions of teens want to quit vaping, study finds
It may be tougher to quit.
New tumor gene test can help predict survival for advanced ovarian cancers: study
A new tumor gene test may.
Risk of coronavirus-related death is higher in obese men and young people, study shows
The risk of dying from coronavirus.